M&T Bank Corp Reduces Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

M&T Bank Corp decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 7.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,909 shares of the company’s stock after selling 3,538 shares during the quarter. M&T Bank Corp owned approximately 0.05% of HealthEquity worth $4,405,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Holocene Advisors LP purchased a new stake in HealthEquity in the 3rd quarter valued at about $1,246,000. GSA Capital Partners LLP purchased a new stake in shares of HealthEquity during the 3rd quarter worth about $638,000. Natixis Advisors LLC grew its holdings in shares of HealthEquity by 29.8% during the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after purchasing an additional 48,009 shares during the period. Vaughan Nelson Investment Management L.P. grew its holdings in shares of HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the period. Finally, Loomis Sayles & Co. L P grew its holdings in shares of HealthEquity by 2.2% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock worth $92,216,000 after purchasing an additional 24,665 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 39,000 shares of company stock valued at $3,895,788. Corporate insiders own 2.20% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the subject of a number of research reports. Royal Bank of Canada boosted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Barrington Research boosted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Raymond James boosted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday, February 25th. Finally, Wells Fargo & Company boosted their price target on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $113.54.

HealthEquity Stock Performance

Shares of HQY opened at $100.58 on Friday. The business’s 50 day moving average is $105.71 and its two-hundred day moving average is $94.21. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The firm has a market cap of $8.72 billion, a price-to-earnings ratio of 92.28, a PEG ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the business earned $0.40 earnings per share. Analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.